Delivery Order SPE2DB20D3104-SPE2DB25FV5D4

Award Date 2/5/25
Potential Completion Date 2/6/25
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,604.96 firm fixed-price contract is for the delivery of 4558761087 LIDOCAINE HCL 2% VIAL 5ML. The award has an ultimate completion date of October 14, 2022. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of 4559396825 - LIDOCAINE HCL 4% SOLUTION 4ML, a pharmaceutical product. The delivery order is valued at $9,018.43 and has a completion date of December 16, 2022. This order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued up to $999,999,999, which provides a comprehensive range of medical commodities to support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of LIDOCAINE HCL 2% 200 MG/10 ML 10ML. The contract has a firm fixed price of $4,135.18 and a completion date of December 24, 2024. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the company's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order worth $1,372.26 to the prime contractor Amerisourcebergen Drug Corp. The contract is for the supply of 4564117299 - LIDOCAINE HCL 2% VISCOUS SOL 40X15 ML UD, a specialty pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary contract vehicle...
This federal contract award was made to Amerisourcebergen Drug Corp, Corporate Office division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at $1,533.00, is a Delivery Order with a Firm Fixed Price awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The contract is for the delivery of 4564381288 - LIDOCAINE HCL 2% VIAL 5ML, with a performance period ending on April 25, 2024. This award is...
The federal contract award SPE2DB22D1106|SPE2DB25FDUT6 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,352.05, is for the delivery of 4566960442 - LIDOCAINE 2% VISCOUS SOLN 100ML. This is a firm fixed price delivery order contract with an ultimate completion date of January 17, 2025. The contract does not have a set-aside designation, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4566478412 LIDOCAINE HCL 2% LUER-JET 5ML. The firm-fixed-price delivery order, valued at $2,963.60, has a completion date of November 19, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award to AmerisourceBergen Drug Corp (AmerisourceBergen) is for the delivery of 4565892411 - LIDOCAINE HCL 2% 200 MG/10 ML 10ML. The award, valued at $3,614.49, was issued by the Defense Logistics Agency (DLA) on September 20, 2024, with a completion date of September 23, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. AmerisourceBergen is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key...
This federal contract award, with ID SPE2DB20D2104|SPE2DB23FV36K, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,034.28 firm fixed price delivery order is for the supply of 4562195302 - LIDOCAINE 2% VISCOUS SOLN 100ML, with a completion date of September 18, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal...
  • SPE2DB20D3104
    Indefinite Delivery Contract
  • SPE2DB20D3104-SPE2DB25FV5D4
    Delivery Order

This federal contract award, with an ID of SPE2DB20D3104|SPE2DB25FV5D4, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567175284 - LIDOCAINE HCL 4% SOLUTION 4ML, with a ceiling value of $1,046.26 and a performance period ending on February 6, 2025.

The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. There is no set-aside designation for this specific contract award.

Generated 5/7/25, 9:53 AM